Concepedia

Publication | Open Access

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

DOIFull Paper Access

396

Citations

35

References

2011

Year

Salvatore De Vita, Luca Quartuccio, Miriam Isola, Cesare Mazzaro, Patrizia Scaini, Marco Lenzi, M. Campanini, Caterina Naclerio, Antonio Tavoni, Maurizio Pietrogrande,
Arthritis & Rheumatism

Abstract

RTX monotherapy represents a very good option for severe CV and can be maintained over the long term in most patients.

References

YearCitations

Page 1